Friday, February 6, 2026

Enhancing Access to Addiction Care: A Quality Improvement Approach

๐ŸŽค Poster Presentation
Presenter: Dr. Andrew Peh Lai Huat
Affiliation: Changi General Hospital, Singapore
Title: Quality Improvement Project: Enhancing Access to Addiction Services for Patients with Alcohol Use Disorder


๐Ÿ” Presentation Highlights
Focus: Addressing the under-detection and under-treatment of alcohol use disorder (AUD) among hospitalized patients.
Background: AUD prevalence among hospitalized patients ranges from 7.4% to 48%, significantly higher than in the general population, yet referrals to addiction services remain low.
Objective: To improve referral rates of patients with alcohol use disorder from the Gastroenterology ward to addiction counseling services.
Methodology:
– Baseline analysis showed only 25 referrals between June 2022 and June 2023.
– Implemented a Plan–Do–Study–Act (PDSA) quality improvement framework.
– Intervention focused on educating junior doctors about the importance of early referral.
Results:
– Achieved a 32% increase in referral rates from July 2023 to July 2024.
– Total referrals increased to 33 cases post-intervention.
Conclusion:
– The project demonstrated the effectiveness of interdepartmental collaboration.
– Highlights how targeted education can significantly enhance patient access to addiction services and overall quality of care.


๐Ÿ‘จ‍⚕️ About the Speaker
Dr. Andrew Peh Lai Huat is a Senior Consultant in the Department of Psychological Medicine at Changi General Hospital, Singapore.
• Medical degree and Master of Medicine (Psychiatry) from the National University of Singapore.
• Fellow of the Academy of Medicine (Singapore).
• Programme Director of the CGH Assessment and Shared Care Team (ASCAT), a community mental health initiative.
• Clinical Assistant Professor at Duke-NUS Graduate Medical School.
• Senior Clinical Lecturer at NUS Yong Loo Lin School of Medicine.
• Faculty member for the National Psychiatry Residency and SingHealth Family Medicine Residency programs.


๐Ÿ”— Join the Conference
Event: International Conference on Addiction Medicine, Mental Health and Psychiatry
๐Ÿ“… March 23–25, 2026
๐Ÿ“ Singapore & Online
๐ŸŒ Website: https://addiction.miconferences.com/
๐Ÿ“ Submit Abstract: https://addiction.miconferences.com/abstract-submission
๐Ÿงพ Register: https://addiction.miconferences.com/register

#AddictionMedicine #MentalHealthConference #PsychiatryConference #AlcoholUseDisorder
#QualityImprovement #AddictionServices #PublicHealth #CommunityMentalHealth
#PosterPresentation #HealthcareInnovation #SingaporeConference #HybridConference
#MentalHealthCare #AddictionResearch #MIconferences

Thursday, February 5, 2026

Enhancing Access to Addiction Services in Hospital Settings

Presenter: Dr. Gabriel Ong Rui Ming
Affiliation: Changi General Hospital, Singapore
Presentation Type: Poster Presentation
Title: Quality Improvement Project:Enhancing Access to Addiction Services for Patients with Alcohol Use Disorder

๐Ÿ”ฌ Presentation Highlights
Public Health Focus: Alcohol use disorder (AUD) remains significantly under-detected and under-treated among hospitalized patients, despite prevalence rates ranging from 7.4% to 48%.
Clinical Gap Identified: AUD is often overlooked in restructured hospitals, leading to missed opportunities for timely intervention.
Objective: To improve referral rates of patients with alcohol use disorder from the Gastroenterology ward to addiction counselling services.
Methodology: Applied the Plan-Do-Study-Act (PDSA) quality improvement framework.
Baseline Data: Only 25 referrals were made between June 2022 and June 2023 prior to intervention.
Intervention: Targeted education of junior doctors on early identification and referral of patients with potential AUD.
Results: Achieved a 32% increase in referral rates from July 2023 to July 2024 (33 total cases).
Conclusion: Demonstrates the power of interdepartmental collaboration and education in improving addiction care pathways and patient outcomes.

๐Ÿ‘จ‍⚕️ About the Speaker
Dr. Gabriel Ong Rui Ming is a psychiatric doctor with nearly a decade of experience in psychiatry. He is currently practicing at Changi General Hospital, Singapore, with a strong interest in addiction services, hospital psychiatry, and quality improvement initiatives aimed at enhancing patient care.

๐Ÿ”— Join the Conference
Event: International Conference on Addiction Medicine, Mental Health andPsychiatry
๐Ÿ“… Dates: March 23–25, 2026
๐Ÿ“ Venue: Singapore & Online
๐ŸŒ Website: https://addiction.miconferences.com/
๐Ÿง  Submit Abstract: https://addiction.miconferences.com/abstract-submission
๐Ÿ“ Register Now: https://addiction.miconferences.com/register

#AddictionMedicine #MentalHealthConference #Psychiatry #AlcoholUseDisorder #QualityImprovement #AddictionServices #HospitalPsychiatry #MentalHealthAwareness #PublicHealth #PsychiatryConference #SingaporeConference #HealthcareInnovation
#MentalHealth2026 #MathewsConferences

Tuesday, February 3, 2026

Reducing Suicide Risk Through Targeted Pharmacological Strategies

Speaker: Thanompong Sathienluckana
Siam University, Thailand
Session Type: Oral Presentation 
Talk Title: Pharmacological pathways for suicide reduction inpsychiatric patients

๐Ÿง  Session Overview
A Critical Global Issue: Suicide remains a leading cause of death globally, with over 700,000 deaths each year and a strong association with psychiatric disorders.
Understanding the Biology: This talk explores key neurobiological mechanisms involved in suicidality, including serotonin dysregulation, neuroinflammation, reduced BDNF, and HPA-axis hyperactivity.
Current Treatment Gaps: Despite advances in psychiatry, no medication is specifically approved for acute suicidal crises—highlighting the need for optimized pharmacotherapy.
Risk-Focused Management: Emphasis on addressing contributory factors such as sleep problems, substance use, medication non-adherence, comorbid illnesses, and psychosocial stressors.
Evidence-Based Medications:
Clozapine: Proven to lower suicide risk in schizophrenia and schizoaffective disorder, with effects beyond antipsychotic action.
Lithium: Demonstrates robust anti-suicidal benefits in mood disorders, independent of mood stabilization.
Ketamine & Intranasal Esketamine: Rapid-onset reduction of depressive symptoms and suicidal ideation in treatment-resistant depression.
SSRIs: Effective in reducing suicide risk in adults and older populations, with age-specific considerations in younger patients.
Clinical Insight: Highlights the importance of correct dosing, continuity of treatment, and close monitoring to prevent relapse and suicidality.

๐Ÿ‘จ‍⚕️ Meet the Speaker
Thanompong Sathienluckana, PharmD, BCP, serves as Associate Dean for Academic Services at the Faculty of Pharmacy, Siam University, and Academic Chair of the Pharmacotherapy Council of Thailand.
∙ Clinical pharmacist at Somdet Chaopraya Institute of Psychiatry, Bangkok
∙ Specialist in neurologic and psychiatric pharmaceutical care
∙ PharmD graduate from Srinakharinwirot University
∙ Board Certified in Pharmacotherapy

๐Ÿ”— Attend the Conference
International Conference on Addiction Medicine, Mental Health and Psychiatry
๐Ÿ“… March 23–25, 2026
๐Ÿ“ Singapore & Online
๐Ÿ“ Register Now: https://addiction.miconferences.com/register

#MentalHealth2026 #AddictionMedicineConference #PsychiatryResearch #SuicidePrevention #Psychopharmacology #ClinicalPharmacy #GlobalMentalHealth #EvidenceBasedCare #SingaporeEvents #HealthcareInnovation #MICONFERENCES #MentalHealthProfessionals #RecoveryPathways #SingaporeConference #HybridConference #MIC2026

Monday, February 2, 2026

Healing at the Root: Emotional Regression as a Transformative Clinical Tool

๐ŸŽ™️ Keynote Speaker Feature: Aaron Olson
Program Director, Cirque Lodge, United States
๐Ÿ“Œ Session Format: Oral Presentation (Onsite & Virtual)
๐Ÿ“˜ Session Title: WalkingBackwards: Using Emotional Regression as a Therapeutic Entry Point in SubstanceUse Disorders, Anger, and Grief


๐Ÿง  Session Overview & Key Insights

Central Theme: Re-envisioning emotional regression as a clinical opportunity that opens pathways to deep healing.
Clinical Relevance: Highlights how substance dependence, persistent anger, and unresolved grief often stem from early relational trauma and emotional injury.
Conceptual Integration: Draws from psychoanalytic foundations, family systems theory, and Acceptance & Commitment Therapy (ACT).
Therapeutic Strategy: Demonstrates how accessing regressive emotional states helps clinicians move past cognitive defenses to reach core developmental wounds.
Applied Techniques: Family identity mapping, genograms, guided imagery, somatic awareness, and narrative repair.
Trauma-Sensitive Practice: Emphasizes safety, containment, and non-retraumatizing interventions.
Clinical Impact: Supports improved emotional regulation, increased psychological flexibility, and strengthened self-compassion.
Practice in Action: Case vignettes illustrating effective regression-focused interventions in SUD, anger, and grief treatment.
Key Message: Regression work is a gateway to sustainable recovery—not an endpoint.


๐Ÿ‘จ‍⚕️ Speaker Profile

With more than three decades of experience in behavioral health, Aaron Olson has been a cornerstone of Cirque Lodge since 2009. His career spans juvenile justice, inpatient psychiatry, residential and outpatient addiction treatment, and community mental health settings.

▪ Expertise in substance use disorders and family systems therapy
▪ Strong ACT-based clinical framework
▪ Special interests include intergenerational trauma, clinician burnout, compassion fatigue, and emotional regression
▪ National speaker on advanced therapeutic approaches
▪ Program Director of Cirque Lodge’s Lodge Program
▪ Faculty member, University of Utah – College of Social Work, Substance Abuse Counseling Program


๐ŸŒ Be Part of the Global Conversation

๐Ÿ“ InternationalConference on Addiction Medicine, Mental Health and Psychiatry
๐Ÿ“… March 23–25, 2026
๐Ÿ“Œ Singapore & Online
๐Ÿ”— Conference Website: https://addiction.miconferences.com/

#AddictionMedicine #MentalHealth2026 #PsychiatryConference #TraumaHealing #SubstanceUseTreatment #ACTTherapy #BehavioralHealthExperts #FamilySystems
#GriefCounseling #AngerManagement #MentalWellbeing #ClinicalInnovation
#HybridConference #SingaporeEvents #MIC2026

Wednesday, January 28, 2026

Integrated Care for Youth with Disruptive Behavior Disorders & Cannabis Use Disorder

Presenter: Tammy Seeker, D.S.W., LCSW, LCDC
(Angelo State University, United States)
Presentation Type: Oral Presentation
Title: The Assessment and Treatment ofDisruptive Behavior Disorders Comorbid with Cannabis Use Disorder


๐Ÿ” Presentation Highlights
Focus: Understanding the complex co-occurrence of disruptive behavior disorders (DBDs) and cannabis use disorder (CUD) among youth.
Clinical Challenge: Youth with DBDs + CUD face elevated risks of family conflict, academic failure, and juvenile justice involvement.
Assessment Tools: Use of structured interviews, behavior checklists, and validated substance use screeners for accurate diagnosis.
Risk Framework: Examination of biopsychosocial risk factors influencing comorbidity and treatment outcomes.
Evidence-Based Treatments:
 – CBT: Enhances emotion regulation and problem-solving skills.
 – MST: Reduces delinquency and substance use through family and peer system interventions.
 – MI: Builds motivation and readiness for change.
 – Contingency Management: Demonstrates effectiveness in reducing cannabis use.
Key Insight: Integrated, multisystemic, and family-involved approaches yield the strongest outcomes.
Future Impact: Early, coordinated intervention leads to reduced recidivism and improved long-term functioning.


๐Ÿ‘ฉ‍⚕️ About the Speaker
Tammy D. Seeker, D.S.W., LCSW, LCDC, is an Adjunct Instructor and Program Coordinator at Angelo State University.
∙ Doctorate in Social Work from Angelo State University.
∙ Extensive clinical and administrative experience in behavioral health, substance use treatment, and criminal justice.
∙ Research interests include justice-involved youth, integrated substance use treatment in hospital settings, and workforce development in social services.


๐Ÿ”— Join the Conference
Event: International Conference on Addiction Medicine, Mental Health andPsychiatry
๐Ÿ“… March 23–25, 2026
๐Ÿ“ Singapore & Online
๐ŸŒ Website: https://addiction.miconferences.com/

#AddictionMedicine #MentalHealthConference #PsychiatryConference #SubstanceUseDisorder #CannabisUseDisorder #BehavioralHealth #YouthMentalHealth #EvidenceBasedPractice #CBT #MultisystemicTherapy #MotivationalInterviewing #JusticeInvolvedYouth #MentalHealthProfessionals #SingaporeConference #HybridConference #MIConferences

Friday, January 23, 2026

Overdose Data to Action: Using Health Informatics to Drive Addiction Prevention

Presenter: Prof. Sue Feldman, RN, MEd, PhD, FACMI 
(University of Alabama at Birmingham, United States)
Presentation Type: Oral Presentation (In-Person / Online)
Title: Overdose data to action: Toward addiction prevention usingdata in Alabama


๐Ÿ” Presentation Highlights
Focus: Leveraging overdose surveillance and health informatics to inform addiction prevention strategies.
Challenge: Despite reduced opioid prescriptions, overdose deaths in Alabama continue to rise.
Approach: Sequential monthly data collection from 11 stakeholder groups, emphasizing peer navigation as a key linkage to care.
Data Strategy: Aggregation by ZIP code to identify high-need areas and guide targeted interventions.
Community Impact:
– 38 community & faith-based events reaching ~12,000 individuals
– 1,589 linkages to care through peer navigation
– 75% of attendees at events received direct services
Surveillance Success: Hospital participation increased to 93 out of 94, supported by enhanced data visualization.
Prevention & Harm Reduction:
– 3,000+ naloxone kits distributed across 94 ZIP codes
– 21,000+ harm reduction service encounters
– 600+ trainings on fentanyl test strip usage
Policy & Practice: Improved PDMP participation with 400+ additional prescribers and hospital-based clinical alerts.
Outcome: Demonstrates the power of data-driven, community-centered, and iterative approaches to addiction prevention.


๐Ÿ‘ฉ‍⚕️ About the Speaker
Prof. Sue Feldman is a Professor and Director of Graduate Programs in Health Informatics at the University of Alabama at Birmingham.
∙ Internationally recognized expert in health information systems for social good
∙ Research funded by the World Bank, Asian Development Bank, CDC, and CMS
∙ Recipient of Changemaker in Health, Mentor of the Year, and Faculty Innovator of the Year awards
∙ Graduate of Claremont Graduate University


๐Ÿ”— Join the Conference
Event: International Conference on Addiction Medicine, Mental Health andPsychiatry
๐Ÿ“… March 23–25, 2026 | ๐Ÿ“ Singapore & Online
๐ŸŒ Website: https://addiction.miconferences.com/



#AddictionMedicine #MentalHealthConference #Psychiatry2026 #OverdosePrevention #PublicHealth #HealthInformatics #OpioidCrisis #HarmReduction #Naloxone #DataDrivenHealth #GlobalHealth #SingaporeConference #AddictionResearch #MentalHealthAwareness #HealthcareInnovation

Thursday, January 22, 2026

Understanding ADHD & Addiction: Bridging Psychiatry and Addiction Medicine

๐ŸŽ™ Presenter: Dr. Hamid-Reza Rahmanian
๐Ÿฅ South West London & St. George’s Mental Health NHS Trust, United Kingdom
๐ŸŽ“ Honorary Senior Lecturer, St George’s, University of London
๐Ÿ“Œ Presentation Type: Oral Presentation
๐Ÿง  Title: The Relationship Between ADHD and Addictive Behaviours: A Review


๐Ÿ”ฌ Presentation Highlights

∙ Adult ADHD Reality: ADHD frequently persists into adulthood and is often underdiagnosed.
∙ High-Risk Comorbidity: ADHD significantly increases the risk of substance use disorders, behavioural addictions, mood disorders, and personality disorders.
∙ Bidirectional Link: ADHD symptoms such as impulsivity can drive addiction, while chronic substance use may worsen ADHD symptoms.
∙ Behavioural Addictions: Strong associations with internet, shopping, and other non-substance addictions.
∙ Clinical Complexity: Treating ADHD alongside substance use disorders remains challenging, especially with stimulant medications.
∙ Treatment Insights: Emphasizes careful differentiation between ADHD patients with and without stimulant/cocaine addiction.
∙ Screening Matters: Recommends routine cross-screening for ADHD and SUD in both mental health and addiction services.
∙ Integrated Care: Highlights the importance of combining pharmacological treatment with psychosocial interventions for better outcomes.


๐Ÿ‘จ‍⚕️ About the Speaker

Dr. Hamid-Reza Rahmanian is a Consultant Psychiatrist and Associate Clinical Director for Sutton Community Mental Health Services at South West London & St George’s NHS Trust. He is a Fellow of the Royal College of Psychiatrists (FRCPsych) with subspecialty experience in perinatal psychiatry.
∙ Over 25 years of clinical and academic experience
∙ Expertise in mood disorders, psychosis, ADHD, eating and personality disorders
∙ Strong advocate of transcultural psychiatry; fluent in Farsi
∙ Leader in community psychiatry transformation, service redesign, and quality improvement
∙ Dedicated educator and mentor in undergraduate and postgraduate medical training
∙ Practices a holistic, biopsychosocial, NICE-aligned approach to mental healthcare


๐Ÿ”— Join the Conference
๐Ÿง  Event: International Conference onAddiction Medicine, Mental Health and Psychiatry
๐Ÿ“… Dates: March 23–25, 2026
๐Ÿ“ Venue: Singapore & Online
๐ŸŒ Website: https://addiction.miconferences.com/


#ADHD #AddictionMedicine #MentalHealthConference #Psychiatry #SubstanceUseDisorder #BehavioralAddictions #NeurodevelopmentalDisorders #AdultADHD #MentalHealthResearch #TransculturalPsychiatry #CommunityPsychiatry #AddictionResearch #PsychiatryConference #MentalHealth2026 #SingaporeConference #MIconferences